相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current trends in West Nile virus vaccine development
Ian J. Amanna et al.
EXPERT REVIEW OF VACCINES (2014)
Evaluation of Dengue Virus strains for human challenge studies
M. P. Mammen et al.
VACCINE (2014)
How advances in immunology provide insight into improving vaccine efficacy
Mark K. Slifka et al.
VACCINE (2014)
Challenges for the formulation of a universal vaccine against dengue
Kulkanya Chokephaibulkit et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Challenges in reducing dengue burden; diagnostics, control measures and vaccines
Sai Kit Lam
EXPERT REVIEW OF VACCINES (2013)
Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response
Kim Blom et al.
JOURNAL OF IMMUNOLOGY (2013)
The Dengue Human Challenge Model: Has the Time Come to Accept This Challenge?
Anna P. Durbin et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Experimental Dengue Virus Challenge of Human Subjects Previously Vaccinated With Live Attenuated Tetravalent Dengue Vaccines
Wellington Sun et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins
Eddie A. James et al.
JOURNAL OF VIROLOGY (2013)
The global distribution and burden of dengue
Samir Bhatt et al.
NATURE (2013)
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
Daniela Weiskopf et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The live attenuated chimeric vaccine rWN/DEN4Δ30 is well-tolerated and immunogenic in healthy flavivirus-naive adult volunteers
Anna P. Durbin et al.
VACCINE (2013)
Vaccination of volunteers with low-dose, live-attenuated, dengue viruses leads to serotype-specific immunologic and virologic profiles
Janet C. Lindow et al.
VACCINE (2013)
Identifying protective dengue vaccines: Guide to mastering an empirical process
Scott B. Halstead
VACCINE (2013)
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation
Adwoa D. Bentsi-Enchill et al.
VACCINE (2013)
Dengue human infection model Re-establishing a tool for understanding dengue immunology and advancing vaccine development
Stephen J. Thomas
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model
Brett A. Thibodeaux et al.
ANTIVIRAL RESEARCH (2012)
Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010
Lara K. Misegades et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
Arunee Sabchareon et al.
LANCET (2012)
Immune Response to Dengue Virus and Prospects for a Vaccine
Brian R. Murphy et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Dengue vaccines: progress and challenges
Beth-Ann G. Coller et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
Critical issues in dengue vaccine development
Stephen J. Thomas et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Vaccines for the prevention of dengue Development update
Stephen J. Thomas et al.
HUMAN VACCINES (2011)
Intracellular Cytokine Production by Dengue Virus-specific T cells Correlates with Subclinical Secondary Infection
Steven Hatch et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Development of DENVax: A chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever
Jorge E. Osorio et al.
VACCINE (2011)
Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
Justin G. Julander et al.
VACCINE (2011)
A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness
V. J. Gunther et al.
VACCINE (2011)
From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
Bruno Guy et al.
VACCINE (2011)
A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes in Flavivirus-Naive Adults
Dennis Morrison et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
Scott B. Halstead et al.
LANCET INFECTIOUS DISEASES (2010)
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
Thaneeya Duangchinda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
Bimmi Shrestha et al.
PLOS PATHOGENS (2010)
Wanted, dead or alive: New viral vaccines
Ian J. Amanna et al.
ANTIVIRAL RESEARCH (2009)
HIV-1 Envelope Induces Memory B Cell Responses That Correlate with Plasma Antibody Levels after Envelope gp120 Protein Vaccination or HIV-1 Infection
Mattia Bonsignori et al.
JOURNAL OF IMMUNOLOGY (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
A Protective Role for Dengue Virus-Specific CD8+ T Cells
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2009)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses
John T. Roehrig et al.
VIRAL IMMUNOLOGY (2008)
Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model
Jennifer L. Kyle et al.
VIROLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection
James D. Brien et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Loss of vaccine-induced immunity to varicella over time
Sandra S. Chaves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax™-DEN2) vaccine:: Phase I clinical trial for safety and immunogenicity
Farshad Guirakhoo et al.
HUMAN VACCINES (2006)
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus
T Oliphant et al.
NATURE MEDICINE (2005)
Safety and efficacy of chimeric yellow fever-dengue virus tetravalent vaccine formulations in nonhuman primates
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2004)
Role of CD8+ T cells in control of West Nile virus infection
B Shrestha et al.
JOURNAL OF VIROLOGY (2004)
CD8(+) T cells mediate recovery and immunopathology in west nile virus encephalitis
Y Wang et al.
JOURNAL OF VIROLOGY (2003)
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: Genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates
F Guirakhoo et al.
VIROLOGY (2002)
Clinical proof of principle for ChimeriVax™:: recombinant live, attenuated vaccines against flavivirus infections
TP Monath et al.
VACCINE (2002)
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: Dose-response effectiveness and extended safety testing in rhesus monkeys
TP Monath et al.
JOURNAL OF VIROLOGY (2000)
分享论文
